课题基金 / 基金详情

DERIVATION, PROPAGATION AND GENETIC MODIFICATION OF RAT EMBRYONIC STEM CELLS

DERIVATION, PROPAGATION AND GENETIC MODIFICATION OF RAT EMBRYONIC STEM CELLS
大鼠胚胎干细胞的衍生、增殖和基因改造
批准号:
8005523
负责人:
Qilong Ying
金额:
$40.22万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-01 至 2014-12-31

项目摘要

项目成果

Qilong Ying的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Rats are more relevant to humans than mice, both physiologically and pharmacologically. The central HYPOTHESIS behind the proposed research is that embryonic stem (ES) cell- based technologies developed for the mouse can be applied to create gene targeted rat models with rat ES cells. Robust and germline competent rat ES cells have been established (Cell 135:1299-310, 2008. Cell 153:1287-98). The overall GOAL of this project is to develop methods for the efficient and routine production of transgenic and gene knock- out rat models for the study of human disease. To achieve this goal, we will: (1) Develop methods to maximize germline transmission efficiency of rat ES cells. (2) Optimize conditions for robust propagation of germline competent rat ES cells. (3) Produce gene targeted rat ES cells and rats. PUBLIC HEALTH RELEVANCE: This study will facilitate the use of rat ES cells as a platform to address fundamental biological questions related to human disease through the creation of disease models.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00018-015-1833-2
发表时间: 2015-05
期刊: Cellular and molecular life sciences : CMLS
影响因子: --
作者: [Huang G, Ye S, Zhou X, Liu D, Ying QL]
通讯作者: Ying QL
Generating gene knockout rats by homologous recombination in embryonic stem cells.
通过胚胎干细胞同源重组产生基因敲除大鼠。
DOI: 10.1038/nprot.2011.338
发表时间: 2011-06
期刊: Nature protocols
影响因子: 14.8
作者: []
通讯作者:
DOI: 10.1097/mnh.0b013e328347768a
发表时间: 2011-07
期刊: Current opinion in nephrology and hypertension
影响因子: 3.2
作者: [Huang G, Ashton C, Kumbhani DS, Ying QL]
通讯作者: Ying QL
DOI: 10.1038/nature09368
发表时间: 2010-09-09
期刊: Nature
影响因子: 64.8
作者: []
通讯作者:
Chicken embryonic stem cells
Rapid egg bioreactor construction for Fabry disease therapeutics
  • 批准号:
    10481061
  • 项目类别:
  • 资助金额:
    $25.95万
  • 财政年份:
    2022
  • 负责人:
    Qilong Ying
  • 依托单位:
Embryonic stem cell self-renewal
Generation of Cre/lox rats
海外基金